Tenax Therapeutics, Inc.

TENX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $1.6M $10.0M $3.7M $58.3M $783.5K $1.9M $951.9K
Accounts Receivable $50.2K $72.6K $49.4K $36.4K $445.2K $13.4K $138.9K
Inventory — — — $0 $99.2K $83.4K $257.4K
Total Current Assets $8.1M $13.6M $20.6M $59.0M $1.8M $2.6M $1.6M
Property, Plant & Equipment $9.9K $19.1K $35.8K $124.4K $205.4K $293.6K $442.6K
Goodwill — $0 $11.3M $11.3M — — —
Intangible Assets (Excl. Goodwill) — $0 $22.0M $23.0M $924.7K $873.0K $700.0K
Total Assets $9.9M $23.3M $73.0M $93.4M $3.2M $4.1M $2.9M
Liabilities
Accounts Payable $611.9K $727.6K $972.5K $411.1K $977.2K $542.8K $889.4K
Total Current Liabilities $1.0M $6.2M $4.6M $2.6M $1.9M $3.1M $2.2M
Long-Term Debt — — — — — — —
Total Liabilities $1.0M $6.2M $12.6M $10.5M $5.0M $4.5M $6.6M
Stockholders' Equity
Retained Earnings $-213.5M $-204.7M $-160.7M $-136.6M $-117.0M $-107.6M $-91.9M
Total Stockholders' Equity $8.9M $17.1M $60.4M $82.9M $-1.8M $-346.0K $-3.7M
← Newer Page 2 of 2 Older →